{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:49:57Z","timestamp":1793368197533,"version":"4.5.0"},"reference-count":129,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Changzhou Municipal Health Commission Science and Technology Project","award":["QY202301"],"award-info":[{"award-number":["QY202301"]}]},{"name":"Changzhou Municipal Health Commission Science and Technology Project","award":["CJ20243007"],"award-info":[{"award-number":["CJ20243007"]}]},{"name":"Changzhou Municipal Health Commission Science and Technology Project","award":["CJ20220064"],"award-info":[{"award-number":["CJ20220064"]}]},{"name":"11th Batch of Science and Technology Plan Projects of Changzhou for 2024","award":["QY202301"],"award-info":[{"award-number":["QY202301"]}]},{"name":"11th Batch of Science and Technology Plan Projects of Changzhou for 2024","award":["CJ20243007"],"award-info":[{"award-number":["CJ20243007"]}]},{"name":"11th Batch of Science and Technology Plan Projects of Changzhou for 2024","award":["CJ20220064"],"award-info":[{"award-number":["CJ20220064"]}]},{"name":"Changzhou Sci&amp;Tech Program","award":["QY202301"],"award-info":[{"award-number":["QY202301"]}]},{"name":"Changzhou Sci&amp;Tech Program","award":["CJ20243007"],"award-info":[{"award-number":["CJ20243007"]}]},{"name":"Changzhou Sci&amp;Tech Program","award":["CJ20220064"],"award-info":[{"award-number":["CJ20220064"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Cholangiocarcinoma (CCA) is an aggressive tumor that originates from the epithelial cells of the bile duct and has the ability to metastasize to the liver or lymph nodes at an early stage. CCA metastasis represents a complex, multi-stage cascade process. Among these stages, the acquisition of invasiveness by CCA cells is a critical prerequisite for metastatic progression. Elucidating the molecular mechanisms driving CCA cell invasiveness is critical for advancing our knowledge in this field. Emerging evidence highlights the critical role of non-coding RNAs (ncRNAs), including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs). These molecules orchestrate key processes such as the epithelial\u2013mesenchymal transition (EMT), as well as the migration and invasion of CCA cells. Collectively, these processes ultimately drive tumor progression. This review comprehensively synthesizes the expression, biogenesis, interactions, signaling pathways, and functional mechanisms of ncRNAs in the invasiveness of CCA. Furthermore, the review discusses potential clinical applications of ncRNAs, including their roles as diagnostic tools, therapeutic targets, and prognostic markers. These investigations offer novel insights and evidence for identifying early metastasis in CCA, developing specific therapeutic strategies, and enhancing drug resistance.<\/jats:p>","DOI":"10.3390\/biomedicines13061369","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T11:55:52Z","timestamp":1748951752000},"page":"1369","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Role and Function of Non-Coding RNAs in Cholangiocarcinoma Invasiveness"],"prefix":"10.3390","volume":"13","author":[{"given":"Yu","family":"Meng","sequence":"first","affiliation":[{"name":"Department of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou 213000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou 213000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5993-7987","authenticated-orcid":false,"given":"Ye","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou 213000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"He","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou 213000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijiao","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou 213000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6922-8762","authenticated-orcid":false,"given":"Jun","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou 213000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3322\/caac.21759","article-title":"Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians","volume":"73","author":"Moris","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000530700","article-title":"Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management","volume":"13","author":"Ye","year":"2024","journal-title":"Liver Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.path.2022.05.006","article-title":"The Molecular Pathogenesis and Targeted Therapies for Cholangiocarcinoma","volume":"15","author":"Param","year":"2022","journal-title":"Surg. Pathol. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ccell.2021.12.006","article-title":"Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma","volume":"40","author":"Dong","year":"2022","journal-title":"Cancer Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"107064","DOI":"10.1016\/j.ejso.2023.107064","article-title":"Epidemiology of cholangiocarcinoma","volume":"51","author":"Qurashi","year":"2025","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S2468-1253(21)00171-0","article-title":"Current and emerging therapies for advanced biliary tract cancers","volume":"6","author":"Kam","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Esmail, A., Badheeb, M., Alnahar, B.W., Almiqlash, B., Sakr, Y., Al-Najjar, E., Awas, A., Alsayed, M., Khasawneh, B., and Alkhulaifawi, M. (2024). The Recent Trends of Systemic Treatments and Locoregional Therapies for Cholangiocarcinoma. Pharmaceuticals, 17.","DOI":"10.3390\/ph17070910"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12943-024-02069-w","article-title":"Cancer, metastasis, and the epigenome","volume":"23","author":"Kiri","year":"2024","journal-title":"Mol. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1158\/0008-5472.CAN-24-4309","article-title":"Tumor Heterogeneity and Cooperating Cancer Hallmarks Driven by Divergent EMT Programs","volume":"85","author":"Carter","year":"2025","journal-title":"Cancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Tomecka, P., Kunachowicz, D., G\u00f3rczy\u0144ska, J., Gebuza, M., Ku\u017anicki, J., Skinderowicz, K., and Choroma\u0144ska, A. (2024). Factors Determining Epithelial-Mesenchymal Transition in Cancer Progression. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25168972"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13045-024-01634-6","article-title":"Harnessing the tumor microenvironment: Targeted cancer therapies through modulation of epithelial-mesenchymal transition","volume":"18","author":"Glaviano","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Pan, X., He, Q., Yin, Y., Xu, A., Wu, A., Yi, X., Zhong, Z., Wu, Y., and Li, X. (2024). Extracellular vesicles of Clonorchis sinensis promote the malignant phenotypes of cholangiocarcinoma via NF-\u03baB\/EMT axis. PLoS Negl. Trop. Dis., 18.","DOI":"10.1371\/journal.pntd.0012545"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Oba, M., Nakanishi, Y., Mitsuhashi, T., Sasaki, K., Hatanaka, K.C., Sasaki, M., Nange, A., Okumura, A., Hayashi, M., and Yoshida, Y. (2023). CCR7 Mediates Cell Invasion and Migration in Extrahepatic Cholangiocarcinoma by Inducing Epithelial-Mesenchymal Transition. Cancers, 15.","DOI":"10.3390\/cancers15061878"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Walter, N.G. (2024). Are non-protein coding RNAs junk or treasure?: An attempt to explain and reconcile opposing viewpoints of whether the human genome is mostly transcribed into non-functional or functional RNAs. Bioessays, 46.","DOI":"10.1002\/bies.202300201"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41422-024-00975-8","article-title":"Coding, or non-coding, that is the question","volume":"34","author":"Poliseno","year":"2024","journal-title":"Cell Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"6451","DOI":"10.1016\/j.cell.2024.10.024","article-title":"Small and long non-coding RNAs: Past, present, and future","volume":"187","author":"Chen","year":"2024","journal-title":"Cell"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10555-023-10127-w","article-title":"Targeting miRNA and using miRNA as potential therapeutic options to bypass resistance in pancreatic ductal adenocarcinoma","volume":"42","author":"Vahabi","year":"2023","journal-title":"Cancer Metastasis Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ijbiomac.2022.11.144","article-title":"A review on the role of ncRNAs in the pathogenesis of cholangiocarcinoma","volume":"225","author":"Safarzadeh","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"101434","DOI":"10.1016\/j.tranon.2022.101434","article-title":"AGO-RBP crosstalk on target mRNAs: Implications in miRNA-guided gene silencing and cancer","volume":"21","author":"Kakumani","year":"2022","journal-title":"Transl. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1017\/erm.2023.7","article-title":"MicroRNAs in cancer metastasis: Biological and therapeutic implications","volume":"25","author":"Sell","year":"2023","journal-title":"Expert Rev. Mol. Med."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Chen, H. (2023). microRNA-Based Cancer Diagnosis and Therapy. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25010230"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Pal, A., Ojha, A., and Ju, J. (2023). Functional and Potential Therapeutic Implication of MicroRNAs in Pancreatic Cancer. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242417523"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1097\/CM9.0000000000002619","article-title":"Non-coding RNAs: A promising target for early metastasis intervention","volume":"136","author":"Xiao","year":"2023","journal-title":"Chin. Med. J."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Wen, K., Chen, X., Gu, J., Chen, Z., and Wang, Z. (2024). Beyond traditional translation: ncRNA derived peptides as modulators of tumor behaviors. J. Biomed. Sci., 31.","DOI":"10.1186\/s12929-024-01047-0"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","article-title":"Long non-coding RNAs: Definitions, functions, challenges and recommendations","volume":"24","author":"Mattick","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41580-023-00694-9","article-title":"Transcription regulation by long non-coding RNAs: Mechanisms and disease relevance","volume":"25","author":"Ferrer","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.21037\/tcr-24-263","article-title":"Integrated analysis of the lncRNA-miRNA-mRNA ceRNA network in nasopharyngeal carcinoma","volume":"13","author":"Li","year":"2024","journal-title":"Transl. Cancer Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1038\/s41388-023-02780-w","article-title":"Going circular: History, present, and future of circRNAs in cancer","volume":"42","author":"Pisignano","year":"2023","journal-title":"Oncogene"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41419-023-05647-w","article-title":"Regulation of the tumor immune microenvironment by cancer-derived circular RNAs","volume":"14","author":"Guan","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/s12276-024-01220-3","article-title":"Molecular mechanisms of circular RNA translation","volume":"56","author":"Hwang","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1261\/rna.035667.112","article-title":"Circular RNAs are abundant, conserved, and associated with ALU repeats","volume":"19","author":"Jeck","year":"2013","journal-title":"RNA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"104612","DOI":"10.1016\/j.critrevonc.2024.104612","article-title":"Circular RNAs as key regulators in cancer hallmarks: New progress and therapeutic opportunities","volume":"207","author":"Hussen","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Kim, J. (2024). Circular RNAs: Novel Players in Cancer Mechanisms and Therapeutic Strategies. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms251810121"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/jmcb\/mjz091","article-title":"IRES-mediated cap-independent translation, a path leading to hidden proteome","volume":"11","author":"Yang","year":"2019","journal-title":"J. Mol. Cell Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"215980","DOI":"10.1016\/j.canlet.2022.215980","article-title":"Circular RNAs in cholangiocarcinoma","volume":"553","author":"Liao","year":"2023","journal-title":"Cancer Lett."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/hep.32232","article-title":"IL-6-induced cGGNBP2 encodes a protein to promote cell growth and metastasis in intrahepatic cholangiocarcinoma","volume":"75","author":"Li","year":"2022","journal-title":"Hepatology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1097\/CM9.0000000000002368","article-title":"L-Fucose inhibits the progression of cholangiocarcinoma by causing microRNA-200b overexpression","volume":"135","author":"Zhu","year":"2022","journal-title":"Chin. Med. J."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Qiao, P., Li, G., Bi, W., Yang, L., Yao, L., and Wu, D. (2015). microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta\/Smad pathway. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1359-x"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"16400","DOI":"10.18632\/oncotarget.24711","article-title":"Extracellular vesicle-encapsulated miR-30e suppresses cholangiocarcinoma cell invasion and migration via inhibiting epithelial-mesenchymal transition","volume":"9","author":"Ota","year":"2018","journal-title":"Oncotarget"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3727\/096504019X15565325878380","article-title":"miR-186 Suppresses the Progression of Cholangiocarcinoma Cells Through Inhibition of Twist1","volume":"27","author":"Zhang","year":"2019","journal-title":"Oncol. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1159\/000354531","article-title":"miR-204 inhibits epithelial to mesenchymal transition by targeting slug in intrahepatic cholangiocarcinoma cells","volume":"32","author":"Qiu","year":"2013","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/hep.28735","article-title":"Extracellular vesicles carry microRNA-195 to intrahepatic cholangiocarcinoma and improve survival in a rat model","volume":"65","author":"Li","year":"2017","journal-title":"Hepatology"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Li, J., Yao, L., Li, G., Ma, D., Sun, C., Gao, S., Zhang, P., and Gao, F. (2015). miR-221 Promotes Epithelial-Mesenchymal Transition Through Targeting PTEN and Forms a Positive Feedback Loop with \u03b2-catenin\/c-Jun Signaling Pathway in Extra-Hepatic Cholangiocarcinoma. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0141168"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"17786","DOI":"10.1002\/jcp.28404","article-title":"microRNA-329 suppresses epithelial-to-mesenchymal transition and lymph node metastasis in bile duct cancer by inhibiting laminin subunit beta 3","volume":"234","author":"Liao","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Tang, Y., Yang, J., Wang, Y., Tang, Z., Liu, S., and Tang, Y. (2020). MiR-19b-3p facilitates the proliferation and epithelial-mesenchymal transition, and inhibits the apoptosis of intrahepatic cholangiocarcinoma by suppressing coiled-coil domain containing 6. Arch. Biochem. Biophys., 686.","DOI":"10.1016\/j.abb.2020.108367"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3892\/ijo.2017.3876","article-title":"miR-21 and KLF4 jointly augment epithelial-mesenchymal transition via the Akt\/ERK1\/2 pathway","volume":"50","author":"Liu","year":"2017","journal-title":"Int. J. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.tcb.2015.07.012","article-title":"Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression","volume":"25","author":"Ye","year":"2015","journal-title":"Trends Cell Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.surg.2013.05.004","article-title":"Epithelial-to-mesenchymal transition predicts prognosis of pancreatic cancer","volume":"154","author":"Yamada","year":"2013","journal-title":"Surgery"},{"key":"ref_49","first-page":"6445","article-title":"LINC01503 promotes cell proliferation, invasion and EMT process in cholangio-carcinoma","volume":"23","author":"Qu","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s13577-020-00448-1","article-title":"Yin Yang 1-induced LINC00667 up-regulates pyruvate dehydrogenase kinase 1 to promote proliferation, migration and invasion of cholangiocarcinoma cells by sponging miR-200c-3p","volume":"34","author":"Li","year":"2021","journal-title":"Hum. Cell."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"152733","DOI":"10.1016\/j.prp.2019.152733","article-title":"Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma","volume":"216","author":"Gao","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biopha.2017.05.061","article-title":"Overexpression of long noncoding RNA H19 indicates a poor prognosis for cholangiocarcinoma and promotes cell migration and invasion by affecting epithelial-mesenchymal transition","volume":"92","author":"Xu","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1515\/hsz-2020-0276","article-title":"PCAT1 induced by transcription factor YY1 promotes cholangiocarcinoma proliferation, migration and invasion by sponging miR-216a-3p to up-regulate oncogene BCL3","volume":"402","author":"Sun","year":"2021","journal-title":"Biol. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.62347\/EQDK1844","article-title":"The long non-coding RNA CCAT1 promotes erlotinib resistance in cholangiocarcinoma by inducing epithelial-mesenchymal transition via the miR-181a-5p\/ROCK2 axis","volume":"14","author":"Zhou","year":"2024","journal-title":"Am. J. Cancer Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41419-020-03346-4","article-title":"Long non-coding RNA LINC00665 promotes gemcitabine resistance of Cholangiocarcinoma cells via regulating EMT and stemness properties through miR-424-5p\/BCL9L axis","volume":"12","author":"Lu","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.2147\/OTT.S127100","article-title":"Long non-coding RNA CCAT2 is associated with poor prognosis in hepatocellular carcinoma and promotes tumor metastasis by regulating Snail2-mediated epithelial-mesenchymal transition","volume":"10","author":"Xu","year":"2017","journal-title":"Onco Targets Ther."},{"key":"ref_57","first-page":"2651","article-title":"Long non-coding RNA CCAT2 promotes gastric cancer proliferation and invasion by regulating the E-cadherin and LATS2","volume":"6","author":"Wang","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.biopha.2018.01.061","article-title":"Long non-coding RNA CCAT2 promotes cholangiocarcinoma cells migration and invasion by induction of epithelial-to-mesenchymal transition","volume":"99","author":"Xu","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"7561","DOI":"10.2147\/OTT.S217676","article-title":"Up-regulated LncRNA-ATB regulates the growth and metastasis of cholangiocarcinoma via miR-200c signals","volume":"12","author":"Lin","year":"2019","journal-title":"Onco Targets Ther."},{"key":"ref_60","first-page":"1455","article-title":"Long non-coding RNA ZEB1-AS1 predicts a poor prognosis and promotes cancer progression through the miR-200a\/ZEB1 signaling pathway in intrahepatic cholangiocarcinoma","volume":"56","author":"Jiao","year":"2020","journal-title":"Int. J. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"22947","DOI":"10.1002\/jcp.28856","article-title":"LncRNA-MEG3 inhibits cell proliferation and invasion by modulating Bmi1\/RNF2 in cholangiocarcinoma","volume":"234","author":"Li","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s13402-021-00644-7","article-title":"Hsa-circ_0058106 induces EMT and metastasis in laryngeal cancer via sponging miR-153 and inducing Twist1 nuclear translocation","volume":"44","author":"Zhang","year":"2021","journal-title":"Cell. Oncol."},{"key":"ref_63","first-page":"2297","article-title":"CircRNA_0023642 promotes migration and invasion of gastric cancer cells by regulating EMT","volume":"22","author":"Zhou","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41419-023-06279-w","article-title":"Specific intracellular retention of circSKA3 promotes colorectal cancer metastasis by attenuating ubiquitination and degradation of SLUG","volume":"14","author":"Deng","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"153901","DOI":"10.1016\/j.prp.2022.153901","article-title":"Upregulation of circ_0059961 suppresses cholangiocarcinoma development by modulating miR-629-5p\/SFRP2 axis","volume":"234","author":"Zhang","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Shi, T., Morishita, A., Kobara, H., and Masaki, T. (2021). The Role of microRNAs in Cholangiocarcinoma. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22147627"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/jcmm.12951","article-title":"The role of microRNAs in intrahepatic cholangiocarcinoma","volume":"21","author":"Li","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.7150\/jca.41492","article-title":"MicroRNA-129-2-3p directly targets Wip1 to suppress the proliferation and invasion of intrahepatic cholangiocarcinoma","volume":"11","author":"Chen","year":"2020","journal-title":"J. Cancer"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"56672","DOI":"10.18632\/oncotarget.18074","article-title":"Wip1 is associated with tumorigenity and metastasis through MMP-2 in human intrahepatic cholangiocarcinoma","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12935-021-01797-z","article-title":"MicroRNA-1182 and let-7a exert synergistic inhibition on invasion, migration and autophagy of cholangiocarcinoma cells through down-regulation of NUAK1","volume":"21","author":"Pan","year":"2021","journal-title":"Cancer Cell Int."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1042\/EBC20240005","article-title":"NUAK: Never underestimate a kinase","volume":"68","author":"Skalka","year":"2024","journal-title":"Essays Biochem."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Yang, R., Chen, Y., Tang, C., Li, H., Wang, B., Yan, Q., Hu, J., and Zou, S. (2014). MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-917"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/mc.23262","article-title":"miR-885-5p inhibits proliferation and metastasis by targeting IGF2BP1 and GALNT3 in human intrahepatic cholangiocarcinoma","volume":"59","author":"Sun","year":"2020","journal-title":"Mol. Carcinog."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1053\/j.gastro.2015.02.056","article-title":"\u03b2-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis","volume":"148","author":"Monga","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41419-018-0286-6","article-title":"Let-7c inhibits cholangiocarcinoma growth but promotes tumor cell invasion and growth at extrahepatic sites","volume":"9","author":"Xie","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_76","first-page":"386","article-title":"MicroRNA-26b-5p regulates cell proliferation, invasion and metastasis in human intrahepatic cholangiocarcinoma by targeting S100A7","volume":"15","author":"Fan","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_77","first-page":"809","article-title":"MicroRNA-7-5p Inhibits Migration, Invasion and Metastasis of Intrahepatic Cholangiocarcinoma by Inhibiting MyD88","volume":"9","author":"Tang","year":"2021","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Fu, W., Yu, G., Liang, J., Fan, P., Dong, K., Zhang, B., Chen, X., Zhu, H., and Chu, L. (2020). miR-144-5p and miR-451a Inhibit the Growth of Cholangiocarcinoma Cells Through Decreasing the Expression of ST8SIA4. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.563486"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/liv.13495","article-title":"Neuropilin-1 regulated by miR-320 contributes to the growth and metastasis of cholangiocarcinoma cells","volume":"38","author":"Zhu","year":"2018","journal-title":"Liver Int."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s10620-010-1481-1","article-title":"miR-373 negatively regulates methyl-CpG-binding domain protein 2 (MBD2) in hilar cholangiocarcinoma","volume":"56","author":"Chen","year":"2011","journal-title":"Dig. Dis. Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/cr.2008.289","article-title":"FXR: A metabolic regulator and cell protector","volume":"18","author":"Wang","year":"2008","journal-title":"Cell Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.gene.2011.11.028","article-title":"MicroRNA-421 functions as an oncogenic miRNA in biliary tract cancer through down-regulating farnesoid X receptor expression","volume":"493","author":"Zhong","year":"2012","journal-title":"Gene"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"Raposo","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.lfs.2018.08.058","article-title":"Dysregulated microRNA expression profiles in cholangiocarcinoma cell-derived exosomes","volume":"210","author":"Kitdumrongthum","year":"2018","journal-title":"Life Sci."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Silakit, R., Kitirat, Y., Thongchot, S., Loilome, W., Techasen, A., Ungarreevittaya, P., Khuntikeo, N., Yongvanit, P., Yang, J.H., and Kim, N.H. (2018). Potential role of HIF-1-responsive microRNA210\/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0199827"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s12033-022-00607-9","article-title":"Tumor Cell-Derived Extracellular Vesicles Promote the Growth, Metastasis and Chemoresistance in Cholangiocarcinoma by Delivering microRNA-210 to Downregulate RECK","volume":"65","author":"Fu","year":"2023","journal-title":"Mol. Biotechnol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s13277-013-0688-0","article-title":"Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis","volume":"34","author":"Chusorn","year":"2013","journal-title":"Tumour Biol."},{"key":"ref_88","first-page":"2757","article-title":"Overexpression of microRNA-96 is associated with poor prognosis and promotes proliferation, migration and invasion in cholangiocarcinoma cells via MTSS1","volume":"19","author":"Yin","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"9720","DOI":"10.1002\/jcb.27286","article-title":"miR-383 promotes cholangiocarcinoma cell proliferation, migration, and invasion through targeting IRF1","volume":"119","author":"Wan","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ajpath.2016.10.021","article-title":"miR-24 Inhibition Increases Menin Expression and Decreases Cholangiocarcinoma Proliferation","volume":"187","author":"Ehrlich","year":"2017","journal-title":"Am. J. Pathol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1159\/000492702","article-title":"miR-122-5p Inhibits the Proliferation, Invasion and Growth of Bile Duct Carcinoma Cells by Targeting ALDOA","volume":"48","author":"Xu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","article-title":"Long Noncoding RNAs in Cancer Pathways","volume":"29","author":"Schmitt","year":"2016","journal-title":"Cancer Cell"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"12611","DOI":"10.1080\/21655979.2021.2011014","article-title":"Long non-coding RNA titin-antisense RNA1 contributes to growth and metastasis of cholangiocarcinoma by suppressing microRNA-513a-5p to upregulate stratifin","volume":"12","author":"Liu","year":"2021","journal-title":"Bioengineered"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"216761","DOI":"10.1016\/j.canlet.2024.216761","article-title":"Stratifin promotes the malignant progression of HCC via binding and hyperactivating AKT signaling","volume":"592","author":"Li","year":"2024","journal-title":"Cancer Lett."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e896","DOI":"10.1002\/ctm2.896","article-title":"Stratifin (SFN) regulates lung cancer progression via nucleating the Vps34-BECN1-TRAF6 complex for autophagy induction","volume":"12","author":"Kim","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/s41419-022-05412-5","article-title":"JUND\/linc00976 promotes cholangiocarcinoma progression and metastasis, inhibits ferroptosis by regulating the miR-3202\/GPX4 axis","volume":"13","author":"Lei","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Zhang, L., Ma, D., Li, F., Qiu, G., Sun, D., and Zeng, Z. (2022). Lnc-PKD2-2-3\/miR-328\/GPAM ceRNA Network Induces Cholangiocarcinoma Proliferation, Invasion and 5-FU Chemoresistance. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.871281"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s10620-024-08798-8","article-title":"NXT629 Ameliorates Cholesterol Gallstones in Mice Model by Improving Lipid Metabolism Disorder and Cholesterol Homeostasis Through Inhibiting the GPAM Pathway","volume":"70","author":"Chen","year":"2025","journal-title":"Dig. Dis. Sci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s10620-021-06876-9","article-title":"Long Non-coding RNA FOXD2-AS1 Promotes Proliferation, Migration, and Invasion in Cholangiocarcinoma Through Regulating miR-760\/E2F3 Axis","volume":"67","author":"Hu","year":"2022","journal-title":"Dig. Dis. Sci."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bbrc.2019.03.054","article-title":"E2F1-induced upregulation of long non-coding RNA LMCD1-AS1 facilitates cholangiocarcinoma cell progression by regulating miR-345-5p\/COL6A3 pathway","volume":"512","author":"Yu","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/tox.23154","article-title":"Long noncoding RNA LINC00184 facilitates the proliferation, metastasis, and adenine metabolism of cholangiocarcinoma via modulating hsa-miR-23b-3p\/ANXA2 axis","volume":"36","author":"Sun","year":"2021","journal-title":"Environ. Toxicol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/kjm2.12354","article-title":"LncRNA NEAT1 promotes cell proliferation, migration, and invasion via the miR-186-5p\/PTP4A1 axis in cholangiocarcinoma","volume":"37","author":"Li","year":"2021","journal-title":"Kaohsiung J. Med. Sci."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Xia, L., Chen, X., Yang, J., Zhu, S., Zhang, L., Yin, Q., Hong, Y., Chen, H., Chen, G., and Li, H. (2020). Long Non-Coding RNA-PAICC Promotes the Tumorigenesis of Human Intrahepatic Cholangiocarcinoma by Increasing YAP1 Transcription. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.595533"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"To, S.Q., Dmello, R.S., Richards, A.K., Ernst, M., and Chand, A.L. (2022). STAT3 Signaling in Breast Cancer: Multicellular Actions and Therapeutic Potential. Cancers, 14.","DOI":"10.3390\/cancers14020429"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41417-024-00726-2","article-title":"LOXL1-AS1 inhibits JAK2 ubiquitination and promotes cholangiocarcinoma progression through JAK2\/STAT3 signaling","volume":"31","author":"Yu","year":"2024","journal-title":"Cancer Gene Ther."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Zhao, W., Zhao, J., Guo, X., Feng, Y., Zhang, B., and Tian, L. (2021). LncRNA MT1JP plays a protective role in intrahepatic cholangiocarcinoma by regulating miR-18a-5p\/FBP1 axis. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-07838-0"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12943-021-01482-9","article-title":"CircNFIB inhibits tumor growth and metastasis through suppressing MEK1\/ERK signaling in intrahepatic cholangiocarcinoma","volume":"21","author":"Du","year":"2022","journal-title":"Mol. Cancer"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13046-024-03006-x","article-title":"N6-methyladenosine-modified circSLCO1B3 promotes intrahepatic cholangiocarcinoma progression via regulating HOXC8 and PD-L1","volume":"43","author":"Li","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13046-023-02699-w","article-title":"CircZNF215 promotes tumor growth and metastasis through inactivation of the PTEN\/AKT pathway in intrahepatic cholangiocarcinoma","volume":"42","author":"Liao","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s13046-023-02813-y","article-title":"Circ-RAPGEF5 promotes intrahepatic cholangiocarcinoma progression by stabilizing SAE1 to facilitate SUMOylation","volume":"42","author":"Zheng","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e00042-20","DOI":"10.1128\/MCB.00042-20","article-title":"Circular RNA CDR1as Exerts Oncogenic Properties Partially through Regulating MicroRNA 641 in Cholangiocarcinoma","volume":"40","author":"Li","year":"2020","journal-title":"Mol. Cell. Biol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jhep.2021.08.027","article-title":"Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription","volume":"76","author":"Chen","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Khosla, D., Misra, S., Chu, P.L., Guan, P., Nada, R., Gupta, R., Kaewnarin, K., Ko, T.K., Heng, H.L., and Srinivasalu, V.K. (2024). Cholangiocarcinoma: Recent Advances in Molecular Pathobiology and Therapeutic Approaches. Cancers, 16.","DOI":"10.3390\/cancers16040801"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Kim, Y., Song, J., Kim, N., and Sim, T. (2025). Recent progress in emerging molecular targeted therapies for intrahepatic cholangiocarcinoma. RSC Med. Chem.","DOI":"10.1039\/D4MD00881B"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1146\/annurev-pathmechdis-051222-122423","article-title":"Update on Epithelial-Mesenchymal Plasticity in Cancer Progression","volume":"19","author":"Fontana","year":"2024","journal-title":"Annu. Rev. Pathol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1186\/s12964-024-01957-4","article-title":"The impact of epithelial-mesenchymal transition (EMT) induced by metabolic processes and intracellular signaling pathways on chemo-resistance, metastasis, and recurrence in solid tumors","volume":"22","author":"Liaghat","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.stem.2007.06.002","article-title":"Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer","volume":"1","author":"Hermann","year":"2007","journal-title":"Cell Stem Cell"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.stem.2010.04.001","article-title":"A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer","volume":"6","author":"Pang","year":"2010","journal-title":"Cell Stem Cell"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1038\/onc.2015.396","article-title":"Genome-wide screen identified let-7c\/miR-99a\/miR-125b regulating tumor progression and stem-like properties in cholangiocarcinoma","volume":"35","author":"Lin","year":"2016","journal-title":"Oncogene"},{"key":"ref_120","first-page":"45","article-title":"lnc-PKD2-2-3, identified by long non-coding RNA expression profiling, is associated with pejorative tumor features and poor prognosis, enhances cancer stemness and may serve as cancer stem-cell marker in cholangiocarcinoma","volume":"55","author":"Qiu","year":"2019","journal-title":"Int. J. Oncol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.2147\/CMAR.S241870","article-title":"Identification of Cholangiocarcinoma Associated with Hepatolithiasis via the Combination of miRNA and Ultrasound","volume":"12","author":"Jiang","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"e23397","DOI":"10.1002\/jcla.23397","article-title":"The association between circulating MicroRNA-150 level and cholangiocarcinoma","volume":"34","author":"Salem","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/hep.31493","article-title":"A Circular RNA, Cholangiocarcinoma-Associated Circular RNA 1, Contributes to Cholangiocarcinoma Progression, Induces Angiogenesis, and Disrupts Vascular Endothelial Barriers","volume":"73","author":"Xu","year":"2021","journal-title":"Hepatology"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Zhou, X., Kong, X., Lu, J., Wang, H., Liu, M., Zhao, S., Xia, Z., Liu, Q., Sun, H., and Gao, X. (2024). Circulating tumor cell-derived exosome-transmitted long non-coding RNA TTN-AS1 can promote the proliferation and migration of cholangiocarcinoma cells. J. Nanobiotechnol., 22.","DOI":"10.1186\/s12951-024-02459-8"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.7150\/ijbs.62602","article-title":"MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs","volume":"18","author":"Yang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"101716","DOI":"10.1016\/j.xcrm.2024.101716","article-title":"Five miRNAs identified in fucosylated extracellular vesicles as non-invasive diagnostic signatures for hepatocellular carcinoma","volume":"5","author":"Li","year":"2024","journal-title":"Cell Rep. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"e24694","DOI":"10.1002\/jcla.24694","article-title":"RNA-sequencing reveals the expression profiles of tsRNAs and their potential carcinogenic role in cholangiocarcinoma","volume":"36","author":"Li","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ncrna.2024.01.003","article-title":"Exosomal MALAT1 promotes the proliferation of esophageal squamous cell carcinoma through glyoxalase 1-dependent methylglyoxal removal","volume":"9","author":"Hu","year":"2024","journal-title":"Noncoding RNA Res."},{"key":"ref_129","first-page":"3729","article-title":"LncRNA MALAT1 inhibits the proliferation and invasiveness of laryngeal squamous cell carcinoma Hep-2 cells by modulating miR-362-3p","volume":"14","author":"Xie","year":"2022","journal-title":"Am. J. Transl. Res."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/6\/1369\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:46:44Z","timestamp":1760032004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/6\/1369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":129,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["biomedicines13061369"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines13061369","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]}}}